3rd Webinar for PATIENTS with EURACAN ERN physician expert on Thymic Tumors
Finding the missing pieces: Empowering Collaboration Patients and Physicians Unite Against Thymic Carcinoma and Thymoma
Organizers: TUTOR and EURACAN
Finding the missing pieces: Empowering Collaboration Patients and Physicians Unite Against Thymic Carcinoma and Thymoma
Organizers: TUTOR and EURACAN
Moderacja:
Na pytania odpowiadali:
The questions submitted by patients before the webinar were answered by doctors:
The webinar was moderated by Dr. Malgorzata Szolkowska, Pathologist, The Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
The following clinical trials for thymic epithelial tumors were presented:
PROGRAM:
Moderator: Chul Kim, Georgetown University, Washington, DC, USA
Presenters:
1. Meredith McAdams, National Cancer Institute, National Institutes of Health, Bethesda, USA:
– (NCT05104736) PT-112 in Subjects with Thymoma and Thymic Carcinoma
– (NCT04417660) Bintrafusp Alfa (M7824) in Subjects with Thymoma and Thymic Carcinoma
2. Dwight Owen, Ohio State University – James Comprehensive Cancer Center, Columbus, OH, USA: (NCT03463460) Pembrolizumab and Sunitinib in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
3. Chris Nabel, Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA: (NCT04262466) Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
4. Annemarie Shepherd, Memorial Sloan Kettering Cancer Center, New York, NY, USA: (NCT05354570) A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest .
5. Q&A
Our experts:
and
answered patients’ questions, submitted before the webinar.
Our experts, thoracic surgeons:
Prof. Paul Van Schil from the Antwerp University Hospital and Antwerp University (Antwerp, Belgium)
and
Prof. Frank Detterbeck from the Yale University School of Medicine (New Haven, CT, USA)
were presenting the various methods of surgical treatment of thymic tumors. After short presentations, experts were answering patients’ questions.
If you are waiting for surgery due to the thymic tumor and want to know what to expect during and after surgery – this video is for you.
In 2021 ITMIG invites thymic epithelial tumor patients for a new series of webinars: EXPERTS EXPLAIN. Our experts are explaining the meaning of many definitions and are answering patients’ questions related with diagnosis and treatment of thymic epithelial tumors. Each webinar contain short presentation(s) and live Q&A (Questions and Answers) part.
Main organizers:
Malgorzata Szolkowska, pathologist, the National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
Pam Bruce, Executive Director of ITMIG, New York, USA
Edith Marom, diagnostic radiologist, The Chaim Sheba Medical Center, Ramat Gan, Israel
This is a recording of the first webinar.
The video contains two presentations dedicated to radiological and histopathological definitions:
1. “Imaging of thymic tumors”, Dr. Chad Strange, Assistant Professor of Thoracic Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA;
2.“How should I understand my diagnosis?”, Dr. Jan von der Thüsen, Consultant Histopathologist, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
Moderator of the webinar: Dr. Malgorzata Szolkowska from the National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
The second webinar was dedicated to surgical treatment of thymic tumors.
Our expert,
Dr. Paul Van Schil, from the Thoracic and Vascular Surgery, the Antwerp University Hospital, Edegem (Antwerp), Belgium
was talking about: “Surgical treatment of mediastinal tumours: from maximally invasive to minimally invasive techniques”.
The webinar was moderated by Dr. Usman Ahmad from the Heart, Vascular and Thoracic Institute, the Cleveland Clinic, Cleveland, OH, USA.
In this webinar radiation oncology matters and definitions will be explained.
Dr. Annemarie Fernandes Shepherd, from the Department of Radiation Oncology, the Memorial Sloan Kettering Cancer Center, New York, USA
was talking about “Radiotherapy of thymic epithelial tumors”.
The webinar was moderated by Prof. Conrad Falkson from the Queen’s University and Kingston Health Sciences Center, Kingston, Ontario, Canada.
Dr. Arun Rajan, from the National Cancer Institute, the National Institutes of Health (NCI/NIH), Bethesda, USA
was explaining oncological issues in a presentation: Oncological Treatment for Advanced Thymic Tumors – Definitions and Strategies.
Moderator of the webinar: Prof. Frank Detterbeck from the Yale University School of Medicine, New Haven, CT, USA.
It is our pleasure to invite you to watch the recording of our last webinar of series EXPERTS EXPLAIN.
Our speakers:
Nicolas Girard, the Institut du Thorax Curie Montsouris, Institut Curie, Paris, France
Arun Rajan, the National Cancer Institute, the National Institutes of Health (NCI/NIH), Bethesda, USA
Heather Wakelee, the Stanford University, Stanford, CA, USA
and Anne Tsao, the University of Texas M.D. Anderson Cancer Center, Houston, USA
are presenting: Clinical Trials for Thymic Epithelial Tumors.
Moderator: Dr. Malgorzata Szolkowska from the National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
NCT03134118: Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
NCT02724696: French National Observatory of Patients With Thymic Epithelial Tumor (RYTHMIC)
Contact: nicolas.girard2@curie.fr
Institute Curie, Paris, France, 75005
Principal Investigator: Nicolas Girard
NCT04417660: Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
Contact: Shannon G. Swift, R.N., phone (+1) (240) 858-3157; email: shannon.swift@nih.gov
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Principal Investigator: Arun Rajan
Contact: phone (+1) 800-811-8480, email: cip@vanderbilt.edu
Stanford Cancer Institute- California
Palo Alto, California, United States, 94304
Principal Investigator: Heather Wakelee
Winship Cancer Institute, Emory University- Georgia
Atlanta, Georgia, United States, 30322
Principal Investigator: Badi El Osta
University of Chicago Medical Center – Illinois
Chicago, Illinois, United States, 60637
Principal Investigator: Christine Bestvina
Baptist Clinical Research Institute – Tennessee
Memphis, Tennessee, United States, 38120
Contact: Baptist Cancer Center Clinical Research Office
Principal Investigator: Philip Lammers
Vanderbilt-Ingram Cancer Center – Tennessee * Coordinating Center
Nashville, Tennessee, United States, 37232
NCT03295227: Feasibility Trial of Pembrolizumab in Unresectable Thymoma and Thymic Carcinoma
Contact: Anne S. Tsao, phone (+1) 713-792-6363, email: astsao@mdanderson.org
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Principal Investigator: Anne S. Tsao
You can find here:
Thank you for your attendance and see you next time!